(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIÇÃO COMBINADA DE PD-1, TGFBETA E TIGIT PARA O TRATAMENTO DE CÂNCER

ArquivadaInvention PatentPCT · EP2020081145

Application data

Number

112022008295

Type

Invention Patent

Filing

11/05/2020

Publication

07/26/2022

PCT

EP2020081145

Progress at the INPI

  1. Filing11/05/20
  2. Publication07/26/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 11/05/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/06/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) LTD.

GB

MERCK PATENT GMBH

DE

Inventors

C. X. (pessoa física)

US

D. Z. (pessoa física)

US

F. J. (pessoa física)

US

Technical data

Priority claims

US

62/930,651 · 11/05/2019

US

63/045,529 · 06/29/2020

US

63/048,351 · 07/06/2020

Abstract

INIBIÇÃO COMBINADA DE PD-1, TGFBETA E TIGIT PARA O TRATAMENTO DO CÂNCER. A presente invenção refere-se a terapias de combinação úteis para o tratamento de câncer. Em particular, a invenção refere-se ao uso combinado de um inibidor de PD-1, um inibidor de TGFß e um inibidor de TIGIT para tratar câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

02/06/2024

RPI 2770

Arquivamento - Art. 33 da LPI

#11.1

11/21/2023

RPI 2759

Notificação de entrada na fase nacional - PCT

#1.3

07/26/2022

RPI 2690

Alteração de dados cadastrais

#1.1

05/10/2022

RPI 2679

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.